Specifications
Immunogen
Synthetic peptide corresponding to a region within the extracellular domain of Human Placental alkaline phosphatase (PLAP)
Applications
Application Notes
WB: 1/10000 - 1/50000; IHC-P: 1/250 - 1/500; ICC: 1/100 - 1/250;
Target
Alternative Names
ALPP; alkaline phosphatase, placental; alkaline phosphatase, placental (Regan isozyme); alkaline phosphatase, placental type; Regan isozyme; PLAP-1; glycerophosphatase; alkaline phosphomonoesterase; placental alkaline phosphatase 1; alkaline phosphatase R
Product Background
Antigen Description
here are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 5 while the tissue non-specific form is located on chme 1. The product of this gene is a membrane bound glycosylated enzyme, also referred to as the heat stable form, that is expressed primarily in the placenta although it is closely related to the intestinal form of the enzyme as well as to the placental-like form. The coding sequence for this form of alkaline phosphatase is unique in that the 3' untranslated region contains multiple copies of an Alu family repeat. In addition, this gene is polymorphic and three common alleles (type 1, type 2 and type 3) for this form of alkaline phosphatase have been well characterized
Pathway
Folate biosynthesis, organism-specific biosystem; Folate biosynthesis, conserved biosystem; Metabolic pathways, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-2813 in a publication?
Let us know and earn a reward for your research.